Parallel Advisors, LLC Takeda Pharmaceutical CO LTD Transaction History

Parallel Advisors, LLC

$4.18 Billion
Q3 2024

A detailed history of Parallel Advisors, LLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Parallel Advisors, LLC holds 9,397 shares of TAK stock, worth $125,731. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,397

Previous 5,575 68.56%

Holding current value

$125,731

Previous $72,000 84.72%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$13.0 - $15.08 $49,686 - $57,635	3,822 Added 68.56%	9,397 $133,000
Q2 2024 Aug 08, 2024	SELL	$12.6 - $13.67 $11,264 - $12,220	-894 Reduced 13.82%	5,575 $72,000
Q1 2024 May 06, 2024	BUY	$13.89 - $15.04 $15,126 - $16,378	1,089 Added 20.24%	6,469 $89,000
Q4 2023 Feb 09, 2024	SELL	$13.36 - $15.43 $23,780 - $27,465	-1,780 Reduced 24.86%	5,380 $76,000
Q3 2023 May 20, 2024	BUY	$15.03 - $16.32 $8,296 - $9,008	552 Added 8.35%	7,160 $110,000
Q3 2023 Nov 13, 2023	BUY	$15.03 - $16.32 $8,296 - $9,008	552 Added 8.35%	7,160 $110,000
Q2 2023 May 20, 2024	BUY	$15.57 - $17.11 $23,868 - $26,229	1,533 Added 30.21%	6,608 $103,000
Q2 2023 Aug 04, 2023	BUY	$15.57 - $17.11 $23,868 - $26,229	1,533 Added 30.21%	6,608 $103,000
Q1 2023 May 20, 2024	SELL	$15.28 - $16.48 $21,300 - $22,973	-1,394 Reduced 21.55%	5,075 $83,000
Q1 2023 Apr 25, 2023	BUY	$15.28 - $16.48 $24,799 - $26,747	1,623 Added 47.02%	5,075 $83,000
Q4 2022 Feb 03, 2023	SELL	$12.42 - $15.62 $98,167 - $123,460	-7,904 Reduced 69.6%	3,452 $53,000
Q3 2022 Nov 10, 2022	BUY	$12.8 - $28.65 $8,192 - $18,336	640 Added 5.97%	11,356 $147,000
Q2 2022 Aug 01, 2022	BUY	$13.12 - $15.03 $8,449 - $9,679	644 Added 6.39%	10,716 $150,000
Q1 2022 Apr 28, 2022	BUY	$13.54 - $15.35 $38,142 - $43,240	2,817 Added 38.83%	10,072 $145,000
Q4 2021 Jan 20, 2022	BUY	$13.17 - $16.4 $17,674 - $22,008	1,342 Added 22.7%	7,255 $99,000
Q3 2021 Nov 02, 2021	BUY	$16.3 - $17.26 $22,445 - $23,767	1,377 Added 30.36%	5,913 $97,000
Q2 2021 Aug 06, 2021	SELL	$16.55 - $18.64 $3,674 - $4,138	-222 Reduced 4.67%	4,536 $76,000
Q1 2021 Apr 23, 2021	BUY	$16.71 - $19.9 $15,941 - $18,984	954 Added 25.08%	4,758 $87,000
Q4 2020 Feb 02, 2021	SELL	$15.39 - $18.97 $9,187 - $11,325	-597 Reduced 13.57%	3,804 $69,000
Q3 2020 Oct 27, 2020	SELL	$17.1 - $19.19 $1,932 - $2,168	-113 Reduced 2.5%	4,401 $79,000
Q2 2020 Jul 16, 2020	BUY	$14.59 - $19.5 $29,311 - $39,175	2,009 Added 80.2%	4,514 $80,000
Q1 2020 Apr 27, 2020	BUY	$13.02 - $20.31 $7,056 - $11,008	542 Added 27.61%	2,505 $38,000
Q4 2019 Jan 30, 2020	BUY	$16.88 - $20.83 $7,663 - $9,456	454 Added 30.09%	1,963 $39,000
Q3 2019 Nov 01, 2019	BUY	$16.15 - $17.99 $17,894 - $19,932	1,108 Added 276.31%	1,509 $26,000
Q2 2019 Aug 05, 2019	SELL	$16.58 - $20.49 $20,260 - $25,038	-1,222 Reduced 75.29%	401 $7,000
Q1 2019 May 01, 2019	BUY	$16.7 - $21.52 $27,104 - $34,926	1,623 New	1,623 $33,000

Others Institutions Holding TAK

# of Institutions

336

Shares Held

73.8M

Call Options Held

1.96M

Put Options Held

165K

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $41.6B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Account

Parallel Advisors, LLC Takeda Pharmaceutical CO LTD Transaction History